Matches in SemOpenAlex for { <https://semopenalex.org/work/W2026519059> ?p ?o ?g. }
- W2026519059 endingPage "e4928" @default.
- W2026519059 startingPage "e4928" @default.
- W2026519059 abstract "To investigate whether there is an increased risk of cardiovascular events in people who exhibit iatrogenic Cushing's syndrome during treatment with glucocorticoids.Cohort study.424 UK general practices contributing to The Health Improvement Network database.People prescribed systemic glucocorticoids and with a diagnosis of iatrogenic Cushing's syndrome (n = 547) and two comparison groups: those prescribed glucocorticoids and with no diagnosis of iatrogenic Cushing's syndrome (n = 3231) and those not prescribed systemic glucocorticoids (n = 3282).Incidence of cardiovascular events within a year after diagnosis of iatrogenic Cushing's syndrome or after a randomly selected date, and association between iatrogenic Cushing's syndrome and risk of cardiovascular events.417 cardiovascular events occurred in 341 patients. Taking into account only the first event by patient (coronary heart disease n = 177, heart failure n = 101, ischaemic stroke n = 63), the incidence rates of cardiovascular events per 100 person years at risk were 15.1 (95% confidence interval 11.8 to 18.4) in those prescribed glucocorticoids and with a diagnosis of iatrogenic Cushing's syndrome, 6.4 (5.5 to 7.3) in those prescribed glucocorticoids without a diagnosis of iatrogenic Cushing's syndrome, and 4.1 (3.4 to 4.8) in those not prescribed glucocorticoids. In multivariate analyses adjusted for sex, age, intensity of glucocorticoid use, underlying disease, smoking status, and use of aspirin, diabetes drugs, antihypertensive drugs, lipid lowering drugs, or oral anticoagulant drugs, the relation between iatrogenic Cushing's syndrome and cardiovascular events was strong (adjusted hazard ratios 2.27 (95% confidence interval 1.48 to 3.47) for coronary heart disease, 3.77 (2.41 to 5.90) for heart failure, and 2.23 (0.96 to 5.17) for ischaemic cerebrovascular events). The adjusted hazard ratio for any cardiovascular event was 4.16 (2.98 to 5.82) when the group prescribed glucocorticoids and with iatrogenic Cushing's syndrome was compared with the group not prescribed glucocorticoids.People who use glucocorticoids and exhibit iatrogenic Cushing's syndrome should be aggressively targeted for early screening and management of cardiovascular risk factors." @default.
- W2026519059 created "2016-06-24" @default.
- W2026519059 creator A5045685914 @default.
- W2026519059 creator A5049780205 @default.
- W2026519059 creator A5087514519 @default.
- W2026519059 date "2012-07-30" @default.
- W2026519059 modified "2023-10-16" @default.
- W2026519059 title "Risk of cardiovascular events in people prescribed glucocorticoids with iatrogenic Cushing's syndrome: cohort study" @default.
- W2026519059 cites W1590759937 @default.
- W2026519059 cites W1942378783 @default.
- W2026519059 cites W1979698089 @default.
- W2026519059 cites W1983013527 @default.
- W2026519059 cites W1987015387 @default.
- W2026519059 cites W2002685360 @default.
- W2026519059 cites W2003578638 @default.
- W2026519059 cites W2008212067 @default.
- W2026519059 cites W2024241244 @default.
- W2026519059 cites W2025656810 @default.
- W2026519059 cites W2033945449 @default.
- W2026519059 cites W2039198400 @default.
- W2026519059 cites W2046816213 @default.
- W2026519059 cites W2052660465 @default.
- W2026519059 cites W2066961578 @default.
- W2026519059 cites W2069381373 @default.
- W2026519059 cites W2073131127 @default.
- W2026519059 cites W2084942885 @default.
- W2026519059 cites W2086453203 @default.
- W2026519059 cites W2086549112 @default.
- W2026519059 cites W2103916194 @default.
- W2026519059 cites W2111366717 @default.
- W2026519059 cites W2111393584 @default.
- W2026519059 cites W2115226306 @default.
- W2026519059 cites W2122415034 @default.
- W2026519059 cites W2124276277 @default.
- W2026519059 cites W2129179042 @default.
- W2026519059 cites W2129546749 @default.
- W2026519059 cites W2134051746 @default.
- W2026519059 cites W2134765554 @default.
- W2026519059 cites W2137293399 @default.
- W2026519059 cites W2138645136 @default.
- W2026519059 cites W2147153810 @default.
- W2026519059 cites W2149899765 @default.
- W2026519059 cites W2160936253 @default.
- W2026519059 cites W2163589808 @default.
- W2026519059 cites W2168809241 @default.
- W2026519059 cites W2169588149 @default.
- W2026519059 cites W2185954894 @default.
- W2026519059 doi "https://doi.org/10.1136/bmj.e4928" @default.
- W2026519059 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3408386" @default.
- W2026519059 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22846415" @default.
- W2026519059 hasPublicationYear "2012" @default.
- W2026519059 type Work @default.
- W2026519059 sameAs 2026519059 @default.
- W2026519059 citedByCount "85" @default.
- W2026519059 countsByYear W20265190592012 @default.
- W2026519059 countsByYear W20265190592013 @default.
- W2026519059 countsByYear W20265190592014 @default.
- W2026519059 countsByYear W20265190592015 @default.
- W2026519059 countsByYear W20265190592016 @default.
- W2026519059 countsByYear W20265190592017 @default.
- W2026519059 countsByYear W20265190592018 @default.
- W2026519059 countsByYear W20265190592019 @default.
- W2026519059 countsByYear W20265190592020 @default.
- W2026519059 countsByYear W20265190592021 @default.
- W2026519059 countsByYear W20265190592022 @default.
- W2026519059 countsByYear W20265190592023 @default.
- W2026519059 crossrefType "journal-article" @default.
- W2026519059 hasAuthorship W2026519059A5045685914 @default.
- W2026519059 hasAuthorship W2026519059A5049780205 @default.
- W2026519059 hasAuthorship W2026519059A5087514519 @default.
- W2026519059 hasBestOaLocation W20265190591 @default.
- W2026519059 hasConcept C120665830 @default.
- W2026519059 hasConcept C121332964 @default.
- W2026519059 hasConcept C126322002 @default.
- W2026519059 hasConcept C187212893 @default.
- W2026519059 hasConcept C201903717 @default.
- W2026519059 hasConcept C207103383 @default.
- W2026519059 hasConcept C2777628954 @default.
- W2026519059 hasConcept C2777698277 @default.
- W2026519059 hasConcept C2779435821 @default.
- W2026519059 hasConcept C44249647 @default.
- W2026519059 hasConcept C500558357 @default.
- W2026519059 hasConcept C61511704 @default.
- W2026519059 hasConcept C71924100 @default.
- W2026519059 hasConcept C72563966 @default.
- W2026519059 hasConceptScore W2026519059C120665830 @default.
- W2026519059 hasConceptScore W2026519059C121332964 @default.
- W2026519059 hasConceptScore W2026519059C126322002 @default.
- W2026519059 hasConceptScore W2026519059C187212893 @default.
- W2026519059 hasConceptScore W2026519059C201903717 @default.
- W2026519059 hasConceptScore W2026519059C207103383 @default.
- W2026519059 hasConceptScore W2026519059C2777628954 @default.
- W2026519059 hasConceptScore W2026519059C2777698277 @default.
- W2026519059 hasConceptScore W2026519059C2779435821 @default.
- W2026519059 hasConceptScore W2026519059C44249647 @default.
- W2026519059 hasConceptScore W2026519059C500558357 @default.
- W2026519059 hasConceptScore W2026519059C61511704 @default.
- W2026519059 hasConceptScore W2026519059C71924100 @default.